bioRASI Is On The 2015 Inc. 500 List
MIAMI, Aug. 13, 2015 /PRNewswire-iReach/ -- Inc. magazine ranked Biorasi amongst the top 500 on its 34th annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies. The list represents the most comprehensive look at the most important segment of the economyAmerica's independent entrepreneurs. Companies such as Microsoft, Pandora, Medidata, Dell, LinkedIn, Zillow, and many other well-known names gained early exposure as members of the Inc. 5000.
"We owe the growth that Biorasi has experienced to our team," says Chairman, Boris Reznik, PhD, during the company's internal announcement of the news, "This is an amazing accomplishment we are all very proud of and I am confident we will continue to achieve great things together."
The 2015 Inc. 5000, unveiled online at Inc.com and with the top 500 companies featured in the September issue of Inc. (available on newsstands August 18 to September 22) is the most competitive crop in the list's history. The average company on the list achieved a mind-boggling three-year growth of 490%. The Inc. 5000's aggregate revenue is $205 billion, generating 647,000 jobs over the past three years. Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at www.inc.com/inc5000.
"The story of this year's Inc. 5000 is the story of great leadership. In an incredibly competitive business landscape, it takes something extraordinary to take your company to the top," says Inc. President and Editor-In-Chief Eric Schurenberg. "You have to remember that the average company on the Inc. 5000 grew nearly six-fold since 2012. Business owners don't achieve that kind of success by accident."
Biorasi is widely recognized as the Leading Biosimilars CRO. Delivering Clinical Research Optimized for Biosimilar clinical trials proves Biorasi succeeds in some of the most complex trials in the industry. TALOS, our innovative project management and optimization platform guides Biorasi studies to success. Equipped with TALOS, Biorasi full service project teams have developed numerous drugs, biologics, and devices that received FDA and multi-venue approvals. Biorasi is headquartered in Miami, FL and has regional offices across North America and around the world. For more information, visit www.biorasi.com.
More about Inc. and the Inc. 500|5000
The 2015 Inc. 5000 is ranked according to percentage revenue growth when comparing 2011 to 2014. As always, Inc. reserves the right to decline applicants for subjective reasons. Companies on the Inc. 500 are featured in Inc.'s September issue. They represent the top tier of the Inc. 5000, which can be found at http://www.inc.com/5000.
About Inc. Media:
Founded in 1979 and acquired in 2005 by Mansueto Ventures, Inc. is the only major brand dedicated exclusively to owners and managers of growing private companies, with the aim to deliver real solutions for today's innovative company builders. Winner of the National Magazine Award for General Excellence in both 2014 and 2012. Total monthly audience reach for the brand has grown significantly from 2,000,000 in 2010 to over 13,000,000 today. For more information, visit www.inc.com.
For more information contact:
Media Contact:Dominique James, Biorasi, LLC, 786-388-0700, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Biorasi, LLC